| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |